RMD

ResMed Inc.NYSEHealthcare

$224.09+0.56%ClosedMarket Cap: $32.71B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-02-02	Citigroup	—	Buy	—
2026-01-30	Piper Sandler	—	Neutral	—
2026-01-30	RBC Capital	—	Outperform	—
2026-01-30	Wells Fargo	—	Equal Weight	—
2026-01-30	Stifel	—	Hold	—
2025-12-18	Stifel	—	Hold	—
2025-12-16	Baird	—	Neutral	—
2025-11-03	Baird	—	Outperform	—
2025-10-31	RBC Capital	—	Outperform	—
2025-10-31	Keybanc	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Wed Jun 30	$12.27	$6.07B	13
Fri Jun 30	$13.43	$6.48B	9
Sat Jun 30	$14.38	$6.97B	3
Sun Jun 30	$16.20	$7.79B	4